COMMUNIQUÉS West-GlobeNewswire

-
Ambu A/S: Ambu updates 2020 strategy and upgrades financial targets in connection with capital markets day 2018
04/10/2018 -
Xbrane Biopharma announces results of in-vivo study showing equivalent tolerability and pharmacokinetic profile of Xlucane compared to Lucentis®
04/10/2018 -
Rule 2.9 Announcement
04/10/2018 -
Saniona Completes Planned Patient Recruitment for Second Part of Phase 2a Study for Tesomet in Prader-Willi Syndrome
04/10/2018 -
Sandoz Healthcare Access Challenge (HACk) returns, seeking digital solutions to local healthcare access challenges
04/10/2018 -
Guardant Health Announces Pricing of Initial Public Offering
04/10/2018 -
Amedisys Extends Employment Agreement with CEO Paul Kusserow
03/10/2018 -
Spring Bank Announces Inarigivir Data Presentations at AASLD Conference
03/10/2018 -
ICC Labs Obtains Interim Order for Arrangement With Aurora Cannabis
03/10/2018 -
KemPharm to Host KOL Investor Event Focused on the ADHD Treatment Landscape
03/10/2018 -
BioPorto receives communication from FDA regarding The NGAL Test™
03/10/2018 -
Retrophin to Highlight Fosmetpantotenate Program for PKAN at Upcoming Medical Congresses
03/10/2018 -
Acasti Pharma Announces Public Equity Offering
03/10/2018 -
Acasti Pharma Announces Proposed Underwritten Public Offering of Common Shares
03/10/2018 -
Corvus Pharmaceuticals Announces Publication of Preclinical Results Highlighting Antitumor Activity of CPI-444 in Multiple Tumor Models both as Monotherapy and in Combination Studies
03/10/2018 -
Paratek Pharmaceuticals, Inc. to Host Investor Day on October 23, 2018
03/10/2018 -
Galapagos increases share capital through warrant exercises
03/10/2018 -
LaSanta Botanicals Announces Closing of $6.4 Million Financing
03/10/2018 -
FDA Grants Orphan Drug Designation to Eidos Therapeutics’ Product Candidate, AG10, for Treatment of Transthyretin Amyloidosis
03/10/2018
Pages